EU to boost investment in Latin American vaccine, drug production – Reuters

European Union flags flutter outside the EU Commission headquarters in Brussels, Belgium June 17, 2022. REUTERS/Yves Herman
BRUSSELS, June 22 (Reuters) – The European Union wants to boost production of vaccines and drugs in Latin America by investing more in the region and by sharing technologies and regulatory practices, the head of the European Commission said on Wednesday.
Under attack in developing countries for blocking a global temporary waiver on COVID-19 vaccine patents, the EU has launched several initiatives to boost production of pharmaceuticals in poorer nations, starting with investments in Africa.
Now Brussels is trying to replicate that model in Latin America.
"The health partnership we are launching today will create stronger, more resilient health systems in Latin America," Ursula von der Leyen said.
The partnership would entail more funding to the Latin American pharmaceutical industry, in addition to 890 million euros ($942.4 million) the EU and its countries are already investing in health projects in the region together with partners such as the Inter-American Development Bank ($1 = 0.9444 euros).
"More will come. We are currently defining our financial support to the biotech sector in Cuba and Mexico," von der Leyen said, adding that the Commission was exploring possible investments also in Chile, Costa Rica, Uruguay and Colombia.
She said the bloc was also committed to sharing health technologies with Latin American countries, to conducting research together and to cooperating on strengthening the regulatory environment.
Our Standards: The Thomson Reuters Trust Principles.
Indonesia will procure 28.7 million vaccine doses for foot and mouth disease by year-end and limit livestock transportation between regions amid a surge in cases, a senior minister said on Thursday.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved


Leave a Reply

Your email address will not be published.